1-3 of 3
Takahiro Kumode
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Trial of OPB-111077 in Combination with Bendamustine (B) and Rituximab (R) in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results of Dose-Escalation Stage

Tomomi Toubai, Junya Kuroda, Youko Suehiro, Yuko Mishima, Kazutaka Sunami, Koji Kato, Nobuhiko Uoshima, Takahiro Kumode, Ai Ota, Kaori Mitsuki, Daisuke Yokota, Yuri Sano, Yasuhito Terui
Journal: Blood
Blood (2023) 142 (Supplement 1): 4464.
https://doi.org/10.1182/blood-2023-179716
Published: 2023
Journal Articles

Interim PET-Guided ABVD or ABVD/Escalated BEACOPP for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma (JCOG1305, INNOVATE-HL study)

Shigeru Kusumoto, Wataru Munakata, Ryunosuke Machida, Takashi Terauchi, Hiroaki Onaya, Masahiko Oguchi, Shinsuke Iida, Kisato Nosaka, Yasuhiro Suzuki, Yasuhiko Harada, Kana Miyazaki, Masaki Maruta, Noriko Fukuhara, Tomomi Toubai, Nobuko Kubota, Ken Ohmachi, Kazuhito Yamamoto, Takahiro Kumode, Ishikazu Mizuno, Takayuki Tabayashi, Hideki Tsujimura, Nobuyuki Takayama, Kohsuke Asagoe, Isao Yoshida, Yasushi Takamatsu, Suguru Fukuhara, Mai Takeuchi, Ukihide Tateishi, Dai Maruyama, Kunihiro Tsukasaki, Hirokazu Nagai
Journal: Blood
Blood (2022) 140 (Supplement 1): 3718–3720.
https://doi.org/10.1182/blood-2022-157006
Published: 2022
Journal Articles

Identification of a Patients-Derived CD34+ Myeloma Cell Population with Tumor-Propagating Capacity and Resistance to Anticancer Drugs

Kentaro Serizawa, Hirokazu Tanaka, MD PhD, Ayano Fukui, MD, Ryosuke Fujiwara, MD, Keigo Sano, MD, Hiroaki Inoue, MD, Takahiro Kumode, MD, Yasuhiro Taniguchi, MD, Yasuyoshi Morita, MD, Luis Espinoza, MDPhD, Itaru Matsumura, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1774.
https://doi.org/10.1182/blood.V130.Suppl_1.1774.1774
Published: 2017